Encontrado 1 documento, a visualizar página 1 de 1
Ordenado por
Data
ir para a página:
1
Phase II study on paclitaxel in patients with recurrent, metastatic or locally ...
Witteveen, PO; van der Velden, J; Vergote, I; Guerra, C; Scarabeli, C; Demonty, G; Reed, NBACKGROUND: No standard treatment options are available for patients with advanced, recurrent or metastatic vulvar carcinoma not amenable for locoregional treatment. PATIENTS AND METHODS: In this phase II study, patients with advanced vulvar cancer received paclitaxel (Taxol) every 3 weeks for up to 10 cycles. Primary objective was response rate. Secondary objectives were response duration and toxicity. Respons...
Data: 2009
|
Origem: Repositório do Centro Hospitalar e Universitário de Coimbra
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||